Ken Griffin Biodesix Inc Put Options Transaction History
Citadel Advisors LLC
- $559 Billion
- Q4 2024
Put Options
6 transactions
Others Institutions Holding BDSX
# of Institutions
63Shares Held
56.6MCall Options Held
2.6KPut Options Held
10.1K-
Telemark Asset Management, LLC Boston, MA8.28MShares$7.95 Million1.33% of portfolio
-
Aigh Capital Management LLC Baltimore, MD6.18MShares$5.93 Million3.75% of portfolio
-
Bryn Mawr Trust CO Bryn Mawr, PA6.1MShares$5.85 Million0.17% of portfolio
-
Birchview Capital, LP Burlington, VT5.58MShares$5.36 Million7.15% of portfolio
-
Silverarc Capital Management, LLC4.33MShares$4.16 Million1.56% of portfolio
About BIODESIX INC
- Ticker BDSX
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 39,982,000
- Market Cap $38.4M
- Description
- Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...